Incidence and tumor characteristics of breast cancer diagnosed before and after implementation of a population-based screening-program

References

• Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. Long-term effects of mammography screening: Updated overview of the Swedish randomised trials. Lancet 2002; 359: 909–19
   PubMed Web of Science ®Google Scholar
• Olsen AH, Njor SH, Vejborg I, Schwartz W, Dalgaard P, Jensen MB, et al. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ 2005; 330: 220
   PubMed Web of Science ®Google Scholar
• The Cancer Registry of Norway. Cancer in Norway, 2005. Oslo: The Cancer Registry of Norway; 2006.
   Google Scholar
• Vainio H, Bianchini F, IARC Handbook of Cancer Prevention Volume 7 Breast Cancer Screening. Lyon: IARCPress; 2002. http://www.iarc.fr.
   Google Scholar
• Perry N, Broeders M, deWolf C, Törnberg S, Holland R, von Karsa L. European guidelines for quality assurance in breast cancer screening and diagnosis. European Communities, 2006. Printed in Belgium. http://europa.eu.int.
   Google Scholar
• Hofvind S, Wang H, Thoresen S. Do the results of the process indicators in the Norwegian Breast Cancer Screening Program predict future mortality reduction from breast cancer?. Acta Oncol 2004; 43: 467–73
   PubMed Web of Science ®Google Scholar
• Hofvind S, Geller B, Vacek P, Thoresen S, Skaane P. Using the European Guidelines to evaluate the Norwegian Breast Cancer Screening Program. Euro J Epidemiol 2007 ( Jun 27).
   Google Scholar
• The Ministry of Health and Social Affairs. Regulations on the collection and processing of personal health data in the Cancer Registry of Norway (Cancer Registry Regulations). Oslo: The Ministry of Health and Social Affairs; 2001.
   Google Scholar
• Tabar L, Tot T, Dean P. Breast Cancer. The art of science of early detection with mammography. Stuttgart, New York: Georg Thieme Verlag; 2005. ISBN 3-13-135371-6 (GTV).
   Google Scholar
• Hofvind S, Sorum R, Haldorsen T, Langmark F. Incidence of breast cancer before and after implementation of mammography screening. Tidsskr Nor Laegeforen 2006; 126: 2935–8
   PubMedGoogle Scholar
• Hofvind S, Moller B, Thoresen S, Ursin G. Use of hormone therapy and risk of breast cancer detected at screening and between mammographic screens. Int J Cancer 2006; 118: 3112–7
   PubMedGoogle Scholar
• Katalinic A, Rawal R. Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy. Breast Cancer Res Treat 2007.
   PubMedGoogle Scholar
• Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: Update of a randomised controlled study. Lancet Oncol 2006; 7: 983–90
   PubMed Web of Science ®Google Scholar
• Zahl PH, Strand BH, Maehlen J. Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: Prospective cohort study. BMJ 2004; 328: 921–4
   PubMed Web of Science ®Google Scholar
• Zackrisson S, Andersson I, Janzon L, Manjer J, Garne JP. Rate of over-diagnosis of breast cancer 15 years after end of Malmo mammographic screening trial: Follow-up study. BMJ 2006; 332: 689–92
   PubMed Web of Science ®Google Scholar
• Hakama M, Holli K, Isola J, Kallioniemi OP, Karkkainen A, Visakorpi T, et al. Aggressiveness of screen-detected breast cancers. Lancet 1995; 345: 221–4
   PubMedGoogle Scholar
• Paci E, Miccinesi G, Puliti D, Baldazzi P, De L, V Falcini F, et al. Estimate of overdiagnosis of breast cancer due to mammography after adjustment for lead time. A service screening study in Italy. Breast Cancer Res 2006;8:R68.
   Web of Science ®Google Scholar
• Quiet CA, Ferguson DJ, Weichselbaum RR, Hellman S. Natural history of node-negative breast cancer: A study of 826 patients with long-term follow-up. J Clin Oncol 1995; 13: 1144–51
   PubMed Web of Science ®Google Scholar
• Michaelson JS, Satija S, Kopans D, Moore R, Silverstein M, Comegno A, et al. Gauging the impact of breast carcinoma screening in terms of tumor size and death rate. Cancer 2003; 98: 2114–24
   PubMedGoogle Scholar
• Fisher B, Costantino J, Redmond C, Fisher E, Margolese R, Dimitrov N, et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 1993; 328: 1581–6
   PubMed Web of Science ®Google Scholar
• Ernster VL, Ballard-Barbash R, Barlow WE, Zheng Y, Weaver DL, Cutter G, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 2002; 94: 1546–54
   PubMed Web of Science ®Google Scholar
• Duffy SW, Tabar L, Vitak B, Day NE, Smith RA, Chen HH, et al. The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the disease. Eur J Cancer 2003; 39: 1755–60
   PubMed Web of Science ®Google Scholar
• Nielsen M, Thomsen JL, Primdahl S, Dyreborg U, Andersen JA. Breast cancer and atypia among young and middle-aged women: A study of 110 medicolegal autopsies. Br J Cancer 1987; 56: 814–9
   PubMed Web of Science ®Google Scholar
• Sanders ME, Schuyler PA, Dupont WD, Page DL. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer 2005; 103: 2481–4
   PubMedGoogle Scholar
• Zackrisson S, Andersson I, Manjer J, Janzon L. Non-attendance in breast cancer screening is associated with unfavourable socio-economic circumstances and advanced carcinoma. Int J Cancer 2004; 108: 754–60
   PubMed Web of Science ®Google Scholar